GenericsWeb - The Search is Over

Generics Event Diary

- Click here to view current events -

5th EGA Pharmacovigilance Discussion Forum
18 January, London, UK:Come and learn directly from the key actors about the new EU pharmacovigilance legislation. Our forum will give you a unique opportunity to ask the right questions and get prepared for the future pharmacovigilance environment.

11th EGA Regulatory and Scientific Affairs Conference
19-20 January, London, UK: Join this year's 10th EGA Regulatory and Scientific Affairs Conference to get an update on recent developments and other important matters. Representatives from the authorities together with well-known experts will present the latest issues and share their point of view on different important topics.

Pharma & Biotech Patent Litigation
31 January - 1 February, London, UK: The 2012 Pharma & Biotech Patent Litigation forum will focus on the latest case law developments on pharma and biotech patents across Europe and the US and how decisions in the various national courts will inevitably impact on the litigation strategies you employ. You will walk away with fresh insights, tactics and tools to strategise your litigation techniques and remain competitive in today’s constantly changing patent landscape.

Pharma IPR India 2012
31 January - 2 February, Mumbai, India:Attend this strategic business conference and get up-to-date on managing IPR and driving global market entry strategy by analysing latest reforms, patentability, and techno-legal intricacies in the pharma and biopharma industry. Register now by calling +91 (022) 4046 1466 or emailing conferences-india@ubm.com and benefit from our limited special discounts

PIUG 2012 Biotechnology Meeting
7 February, Boston, USA: Welcome back to Boston for the sixth annual PIUG Biotechnology Meeting! This national meeting focuses on methodologies and resources for patent information professionals who specialize in biotechnology search and analysis. This year’s theme is Competitive Intelligence: Meeting Current Challenges in Biotechnology. New tools, or new uses for old tools, are needed to investigate competitors in biotechnology. Challenges include transforming patent data on biotech targets into strategic knowledge for decision making and monitoring the competition to keep up with new biotechnologies.

Informex USA
14-17 February, New Orleans, USA: Our event is known for its manageable size and family feel. We serve businesses across a broad range of end-use markets such as pharmaceuticals, biopharmaceuticals, agrochemicals, adhesives, electronics, paints, and plastics. We utilize an advisory committee, made up of industry executives and decision makers from across markets to help us make decisions that come directly from the chemical industry.

2012 Pharma CI Europe Conference & Exhibition
21-22 February, Hilton Zurich Airport Hotel, Zurich, Switzerland : The Best and Largest Assembly of Pharmaceutical Competitive Intelligence Executives! The Pharma CI Europe Conference & Exhibition is THE INDUSTRY'S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the rare chance to network with all the industry's luminaries (40+ speakers!). More than 300 people came to the U.S. event in 2011! Now it’s Europe’s turn.
This is the biggest and best gathering of pharmaceutical competitive intelligence thought leaders! For more information, call +1-212-228-7974, visit http://pharmaciconference.com/ or email info@pharmaciconference.com

GPhA 2012 Annual Meeting
22-24 February, Orlando, US: Join us for GPhA's 2012 Annual Meeting on February 22-24. More than 500 attendees convene in Orlando, Florida to gain perspective on the most important emerging issues facing the generic pharmaceutical sector. The program agenda includes addresses by generic industry CEOs along with broad plenary session presentations that provide valuable insight into the current and future business climate for generic medicines. Registration is now open. See you there!

World Generic Medicines Congress Europe 2012
28 February - 2 March, Millennium Gloucester – London, UK: World Generic Medicines Europe Congress attracts attendees from leading generic pharma manufactures, investment banks, pharmaceutical wholesale, law firms and API manufacturers to discuss the latest developments in the generics industry.
Hear from: Watson, Synthon, Pfizer, Dr Reddy’s, Towa Pharmaceuticals Japan, Hospira, European Commission and many more!
For more information visit: http://www.healthnetworkcommunications.com/genuk or call Sabrina on +44 (0) 207 608 7055 or email skhamissa@healthnetworkcommunications.com

Biosimilar Drug Development World Europe 2012
28 February - 2 March, Millennium Gloucester, London, UK: The Leading scientific event for biosimilar drug development. Biosimilar Drug Development World provides you with the strategy and science to take biosimilars from bench to market.

Global Pharma Regulatory Summit India 2012
28 February - 2 March, Mumbai, India: Attend this strategic business conference and get up-to-date on implementing best practices to ensure flawless execution of stringent regulatory guidelines in regulated and emerging markets to drive the exports of Indian generics globally. Register now by calling +91 (022) 4046 1466 or emailing conferences-india@ubm.com and benefit from our limited special discounts!

euroPLX 48 Lisbon
5-6 March, Cascais (near Lisbon), Portugal: As one of the industry's most international partnering events for business deals euroPLX features delegates from an average of 36 countries attending each event. You will only meet pharma and biopharma executives who are in charge of their companies' business development. euroPLX stands for for continuous, productive pharma partnering since 1995.
Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event, displayed on www.europlx.com. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution.

5th annual BioPharma Asia Convention 2012
19-22 March, Marina Bay Sands, Singapore: BioPharma Asia Convention is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CMOs, CROs, academic institutions, investors and all other industrial stakeholders to assess the latest industrial trends, partnership models and solutions in Asia.
This is the largest biopharmaceutical gathering in Asia featuring multiple conferences, summits and seminars that covers the entire value chain of the biopharma industry. Biopharma Asia Convention 2012 will show you how you can access the important markets in Asia that matters most to your business. Over four days, more than 2,000 decision makers from leading biopharmaceutical companies from Asia and globally will gather at this event.

8th EGA Legal Affairs Forum
22-23 March, Brussels, Belgium: This session will focus on the recent developments on SPCs:
• SPC caselaw and legislation update
• Combination products in the pipeline
• Litigating SPCs around Europe - escitalopram case study
• Roundtable presentations on national escitalopram SPC cases: Germany, France, The Netherlands, Belgium
• Privilege in litigation in Europe
• US perspective on Privilege
• Privilege and European Commission investigations/patent settlement cases
• Views on the review of Directive 2004/48/EC on the enforcement of IP rights
• Views on the changes in the EU patent system: single court and patent with unitary effect
• Update on court cases that impact the industry

3rd Annual Biosimilars India 2012
27-29 March, Hyderabad, India: Attend this strategic business conference and get up-to-date on formulating practical strategies around stringent domestic and international regulatory protocols and R&D challenges to propel your biosimilar commercialisation strategies to the next level. Register now by calling +91 (022) 4046 1466 or emailing conferences-india@ubm.com and benefit from our limited special discounts!

3rd Annual Generic Medicine Middle East Summit
18-19 April, Abu Dhabi, United Arab Emirates : The M.C.C Group’s premier event brings together a distinguished selection of pharma generic specialists and industry professionals to share their knowledge and outlook on the current generic industry. The industry-leading speakers and guest delegates will network and learn over two days how to overcome market challenges and regulations, relationship with branded manufacturers and develop strategies in the generic pharmaceutical market.

Pharmaceutical Portfolio & Lifecycle Management
18-19 April, London, United Kingdom: Join SMi at their 7th annual Pharmaceutical Portfolio & Lifecycle Management that will address the challenges associated with obtaining an optimal portfolio of projects. Senior level industry executives will discuss key strategies and management approaches essential to effective portfolio and lifecycle management.
For more information visit http://www.smi-online.co.uk/pharma-portfolio14.asp or contact Fateja Begum on +44 0207 827 6184 or email fbegum@smi-online.co.uk

How to create a generic drug IP strategy - Free webinar
19 April, your desk!: Come and meet the EU and international regulators and the leading EU companies in biosimilars. The pre-symposium workshop will explore the mechanics of the Biologics Act with an emphasis on how the Act relates to the involved intellectual property and how the intellectual property may impact the biosimilar applicant’s strategy for entering the market.

10th EGA International Symposium on Biosimilar Medicine
19-20 April, London, United Kingdom: Come and meet the EU and international regulators and the leading EU companies in biosimilars. The pre-symposium workshop will explore the mechanics of the Biologics Act with an emphasis on how the Act relates to the involved intellectual property and how the intellectual property may impact the biosimilar applicant’s strategy for entering the market.

Biosimilars Asia 2012
23-26 April, Shanghai, China: IBC’s 3rd Annual Biosimilars Asia 2012 is the largest and most anticipated meeting of its kind in Asia. Attended by biosimilars, innovators, generics and biopharma alike, the unique mix of attendees from all over the world will share their experiences and opinions about the future of biosimilars. Tough questions will be answered and positions will be challenged but all will walk away bristling with ideas, opportunities and be more informed. Biosimilars Asia 2012 continues to deliver a quality of speakers and discussions unmatched in Asia.

PIUG 2012
28 April - 3 May, Denver, USA: The conference will feature world-renowned experts on patent information for technology research and planning, for legal organizations, and for overall corporate IP management (technology licensing and related activities). The conference will include many opportunities for discussion and part of Tuesday afternoon will be dedicated to visiting the exhibit hall. Many workshops will also be held in conjunction with this meeting (before, during and after the technical sessions.

INTERPHEX™ New York
1-3 May, New York, USA: INTERPHEX™ is the leading annual pharmaceutical and biopharmaceutical trade show. Key decision makers find the networking opportunities, products, services and information they need to ensure quality and maximize efficiency, agility, and flexibility that solve manufacturing and supply chain problems. INTERPHEX is where intelligence and passion intersect with the full spectrum of industry products and services to create new insights and innovation. Find out more at www.interphex.com

15th annual Generics, Supergenerics and Patent Strategy.
14-15 May, London, United Kingdom: SMi is pleased to announce their 15th annual Generics, Supergenerics and Patent Strategy. The event will cover some of the current regulatory issues and also an assessment on the European generics markets and the pressures faced in this increasingly saturated region, branded generics, their value for money and how they actually perform in the market, evaluation of recent moves by large pharma companies into the generics markets and some generics producing companies moving into innovative drugs. Visit http://www.smi-online.co.uk/generic-pharma7.asp

2012 GPHA/FDA CMC Workshop
22-23 May, North Bethesda, USA: The CMC Workshop will address in detail FDA's new approaches for review and filing expectations for Type II DMFs, stability and batch considerations for ANDAs, incorporation of risk assessment and design of experiments to establish critical quality attributes, critical material attributes, and critical process parameters and their relationships. FDA will also report the FDA OGD's progress in revising QbR questions to incorporate quality target product profile, product and process design and understanding. Space is limited, Register Today!

Korea Pharm 2012
22-25 May, Goyang, Korea: organized by Korea Food & Drug Administration is the professional exhibition of pharmaceutical industry in KOREA showing pharmaceutical ingredient. It will be held in KINTEX, Goyang, from May 22 to 25 with 650 companies from 23 countries participating. Promoting and globalizing the Korean Pharmaceutical market, the exhibition purposes supporting to launching global market. It is the best marketplace to promote goods and services of your company.

euroPLX 49
4-5 June, Istanbul, Turkey: Almost 50 successfully held euroPLX Meetings make this partnering conference the life science industry's most often held partnering event for business deals. With delegates from an average of 36 countries attending each event it is also one of the most interenational around.
The partnering scope of euroPLX 49 Istanbul will range from innovative to generic, from early stage candidates to approved, prescription or OTC drugs, medical devices and companion diagnostics.

18th EGA Annual Conference
13-15 June, Malta: Join your colleagues to gain the latest information on the most important emerging issues facing the generic pharmaceutical industry. The keynote speech this year is: “the European union’s vision in the European year for active ageing and solidarity between generations – what role for generic and biosimilar medicines?” Commissioner John Dalli, European Commissioner for Health and Consumers.

11th Annual International Maximising Pharma Patent Life cycles
20-21 June, London, United Kingdom: C5’s 11th Annual Forum on Pharma Patent Lifecycles brings together eminent in-house counsel from the world’s largest pharma and biotech companies and their expert advisors from a range of jurisdictions, including the US, Europe and Asia. Be where your industry will be on 20th and 21st June 2012 and don’t miss out on this unique opportunity to hear from and network with prominent judicial authorities, regulatory experts and industry specialists.
For more info, please visit our website: http://www.c5-online.com/2012/509/pharma-patent-lifecycles

5th Product and Pipeline Enhancement for Generics Conference
17-19 July, Washington, USA: The marcus evans 5th Product and Pipeline Enhancement for Generics Conference will host industry leaders within the Generic Pharmaceutical, Branded Pharmaceutical and API industries operating globally as they share best practices, strategies and tools on portfolio management and business strategy, as well as legal, intellectual property and patent issues.
Speakers include Harvest Moon Pharmaceuticals, Glenmark Pharmaceuticals, Amneal Pharmaceuticals, Federal Trade Commission, Sandoz Inc., Orchid Pharma, Inc. and many more!

5th Annual Pharmaceutical Regulatory Affairs Asia 2012
21-24 August, Sheraton Towers, Singapore: IBC’s focus in 2012 for its Pharmaceutical Regulatory Summit is to provide a platform for open discussion among the field including industry and authority professionals about common issues and challenges with regulatory approval in Asia and moving forward with strategies for the efficient approval of safe drugs. Frank discussions on what is required to get your products APPROVED. For more information, visit: http://www.pharmaregulatoryasia.com or email: register@ibcasia.com.sg or call +65 6508 2401

Business of Biosimilars 2012
10-12 September, Boston, USA: Now in its 13th year, the Business of Biosimilars & Generic Drugs is the world's largest development and commercialization event for the follow-on biopharmaceutical industry, bringing drug development and market access executives the tools to compete and maximize pipeline profitability in today's global competitive environment.

2012 Pharma CI Conference & Exhibition
11-12 September, Parsippany, USA: The Best and Largest Assembly of Pharmaceutical Competitive Intelligence Executives! The Pharma CI Conference & Exhibition is THE INDUSTRY'S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the rare chance to network with all the industry's luminaries. More than 300 people came in 2011! This is the biggest and best gathering of pharmaceutical competitive intelligence thought leaders (75+ speakers)! For more information, call +1-212-228-7974, visit http://pharmaciconference.com/ or email info@pharmaciconference.com.

World Biosimilars Congress Europe 2012
11 - 12 September 2012, London, UK: Gain a competitive insight into global regulatory pathways and best-practice development and manufacturing protocols, in order to successfully take both biosimilar drugs to market in developed and developing countries. And find out how to do it quickly! Industry experts will identify strategies for shortening the production timescale, while still maintaining product safety and quality.
Use the Generics Web subscriber discount code WTGE for maximum savings on your registration!
Click here to register.

Generics & Biosimilars Conference 2012
18-20 September, Istanbul, Turkey: Organised by CPhI Conferences and following the success of last year’s Generics and Biosimilars Strategies EMEA conference, the 2012 Generics & Biosimilars Conference on 18-20 September offers an agenda on product developments, partnerships and strategies from the fastest growing markets. Together with an expert speaker line-up, this really is the must attend event for Pharma Executives who want the very latest up to date industry information on generic and biosimilars. For more information email louise.slade@ubm.com or view the conference programme

SMi’s 3rd annual Biosimilars and Biobetters
24-25 September, London, United Kingdom: Join SMi at their third Biosimilars and Biobetters conference that will discuss the impact of these new regulatory guidelines and their effects on approval of follow on biologics at this exciting event. There will also be discussions on the rising development cost of biosimilars and marketing and pricing strategies, with a focus on case studies from those who are both developing and distributing follow on biologics. You cannot afford to miss this event. Visit http://www.smi-online.co.uk/events/overview.asp?is=4&ref;=4011&utm;_source=P-043&utm;_medium=EINNews&utm;_campaign=WebBanner

2012 GPhA/FDA Fall Technicak Conference
1-3 October, North Bethesda, USA: Come learn and listen to top FDA officials who make up the speaking faculty at this premier generic industry science and regulatory meeting. The Fall Technical Conference now attracts more than 600 industry professionals. Last year the meeting sold out, space is limited, early registration is recommended to secure your spot. Register Today!

13th Annual Maximizing Pharmaceutical Patent Lifecycles
10-11 October, New York, USA: American Conference Institute’s (ACI’s) Maximizing Pharmaceutical Patent Life Cycles conference is the pharmaceutical industry’s leading and integral source for information and analysis on patent life cycle management for both small and now large molecule pharmaceutical products. It is the forum where lawyers, executives and policy makers for brand name and generic manufacturers gather each year to prepare for the life cycle challenges they currently face as well as those which they anticipate.
Generics Web members are entitled to a discount when referencing the code: GW 200

23rd Annual Forum on Biotech & Pharmaceutical Patenting
10-11 October, London, UK: In a rapidly shifting legal environment for the pharma industry, it has become crucial that biotech companies seek the most practical and competitive strategies for obtaining, extending and protecting their patent portfolios. The 2012 London Biotech & Pharmaceuticals Patenting forum will focus on latest legal developments affecting biotech companies, with a particular focus on successful techniques and strategies for drafting and filing patent applications in multiple jurisdictions. The event will provide a unique opportunity for you to network with your fellow industry peers, key industry regulators and expert patent attorneys from across globe, allowing you to develop your current biotech practices and remain competitive in today’s rapidly changing market.

7th the Generics Asia Summit
15-17 October, Grand Copthorne Waterfront Hotel, Singapore: Following our highly acclaimed summit last year, Generics Asia has been rebranded to keep up with the needs of the industry. The 7th Summit: Branded Generics Strategy Asia will continue to focus on the ever-changing generics industry. As part of our goal to keep you updated and ahead of your competitors, this year’s conference will address the following main topics: Branded generics (BGx), supergenerics and pricing. Join your peers and industry speakers from pharmas and leading generics companies to share experiences and knowledge. For more information, visit: http://www.generics-asia.com or email: register@ibcasia.com.sg or call +65 6508 2401

euroPLX 50 Sorrento
5-6 November, Sorrento, Italy: euroPLX is one of the life science and pharmaceutical industry's most international and most often held partnering events for business deals, now celebrating its 50th anniversary partnering conference. The partnering scope of euroPLX 50 Sorrento (Italy, 5 + 6 November 2012) will range from innovative to generic, from early stage candidates to approved, prescription or OTC drugs, medical devices and companion diagnostics

World Generic Medicines Congress US
27-29 November, Washington, US: The largest North American generic medicines strategy event, this conference addresses the health economics, pricing and competition pressures facing the generic medicines sector in the US and building scale and value through globalization.

Biosimilar Drug Development World Americas 2012
27-29 November, Washington, US: The leading scientific event for biosimilar drug development, this conference provides you with the strategy and science to take biosimilars from bench to market.

Pharmaceutical Quality and Compliance Asia Summit 2012
27-30 November, Singapore : Current economic pressures and regulatory drive towards risk-based systems are the impetus for pharma companies to move towards quality-focused systems to remain competitive in the market. Quality can no longer be an after-thought, but rather built into systems and processes from the outset. IBC’s inaugural Pharma Quality & Compliance Summit Asia will target a multidisciplinary audience from R&D; to process development to manufacturing to quality. It will present the business case and provide practical strategies to build quality systems across the product lifecycle. For more information, visit: http://www.pharmaquality-compliance.com or email: register@ibcasia.com.sg or call +65 6508 2401

Pharma Anti-Counterfeiting & Brand Protection Asia
27-30 November, Singapore : The ONLY event in Asia focused on anti-counterfeiting and brand protection, bringing together key stakeholders from Regulators + Enforcement + Pharma + Technology Providers. As the pharma industry’s blockbusters come off patent and both market share and margins come under increasing pressure from growing competition, attention is turning towards the damage caused by counterfeit and fake drugs. Aside from the inherent risk to patient safety, estimates place the trade of counterfeit drugs to as much as GBP 75 bn with a growth rate of 13% annually. For more information, visit: http://www.pharmabrandprotection-asia.com or email: register@ibcasia.com.sg or call +65 6508 2401

2nd annual Biosimilars forum
28-29 November, Munich, Germany : C5’s 2nd annual Biosimilars forum is a unique event specifically tailored to the legal community handling biosimilars. It is based on extensive research with in-house legal counsel navigating the regulatory landscape for the leading pharmaceutical companies, the lawyers advising them, and the patent attorneys conducting freedom to operate analysis and formulating patent defence strategies.

15TH Annual International Generic Pharmaceutical Conference
4-6 December, Kyoto, Japan: Organized by Japan Generic Medicines Association for International Generic Pharmaceutical Alliance includes 2-track workshops by regulatory officials from six countries in the Asia-Pacific region and a special session by Dra. Lucky S. Slamet, Head of NA-DFC, Indonesia; two-day Main Conference of seven sessions covering various recent hot issues such as biosimilars, tenders, ecent M&As;, FTAs, etc. For more information, visit www.congre.co.jp/igpa2012

Add your event